The intracellular expression pattern of the human papillomavirus type 11 E1:E4 protein correlates with its ability to self associate

Virology

Volumn 241, Issue 1, 1998, Pages 49-60

  Bryan, Janine T ^a   Fife, Kenneth H ^a   Brown, Darron R ^a,b  

^a INDIANA UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b Richard L Roudeboush V A M C   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

VIRUS PROTEIN;

AMINO ACID SEQUENCE; AMINO ACID SUBSTITUTION; ARTICLE; CONFOCAL MICROSCOPY; CONTROLLED STUDY; HUMAN; HUMAN CELL; KERATINOCYTE; OPEN READING FRAME; PRIORITY JOURNAL; PROTEIN ASSEMBLY; VIRUS CELL INTERACTION; VIRUS GENE; WART VIRUS;

DNA VIRUSES; HUMAN PAPILLOMAVIRUS; HUMAN PAPILLOMAVIRUS TYPE 11; HUMAN PAPILLOMAVIRUS TYPES;

EID: 0032004652     PISSN: 00426822     EISSN: None     Source Type: Journal    
DOI: 10.1006/viro.1997.8965     Document Type: Article

References (34)

1. Current Protocols. 1989;Wiley, New York.
2. Bartel P. L., Chien C. T., Sternglanz R., Fields S. Using the two-hybrid system to detect protein-protein interactions. Cellular Interactions in Development: A Practical Approach. 1993;IRL Press, Oxford. p. 153-179.
3. Brown D. R., Chin M. T., Strike D. G. Identification of human papillomavirus type 11 E4 gene products in human tissue implants from athymic mice. Virology. 165:1988;262-267.
4. Brown D. R., Bryan J. T., Cramer H., Fife K. H. Analysis of human papillomavirus types in exophytic condylomata acuminata by hybrid capture and Southern blot techniques. J. Clin. Microbiol. 31:1993;2667-2673.
5. ∧. Virology. 201:1994;46-54.
6. ∧. Virology. 214:1995;259-263.
7. ∧∧∧. Virology. 222:1996;43-50.
8. Chalfie M., Tu Y., Euskirchen G., Ward W. W., Prasher D. C. Green fluorescent protein as a marker for gene expression. Science. 263:1994;802-805.
9. Chow L. T., Nasseri M., Wolinsky S. M., Broker T. R. Human papillomavirus types 6 and 11 mRNAs from genital condylomata acuminata. J. Virol. 61:1987;2581-2588.
10. Cormack B. P., Valdivia R. H., Falkow S. FACS-optimized mutants of the green fluorescent protein (GFP). Gene. 173:1996;33-38.
11. Cubitt A. B., Heim R., Adams S. R., Boyd A. E., Gross L. A., Tsien R. Y. Understanding, improving and using green fluorescent proteins. Trends Biochem. Sci. 20:1995;448-455.
12. Doorbar J., Evans H. S., Coneron I., Crawford L. V., Gallimore P. H. Analysis of HPV-1 E4 gene expression using epitope-defined antibodies. EMBO J. 7:1988;825-833.
13. Doorbar J., Coneron I., Gallimore P. H. Sequence divergence yet conserved physical characteristics among the E4 proteins of cutaneous human papillomaviruses. Virology. 172:1989;51-62.
14. Doorbar J. An emerging function for E4. Papillomavirus Rep. 2:1991;145-147.
15. Doorbar J., Ely S., Sterling J., McLean C., Crawford L. Specific interaction between HPV-16 E1-E4 and cytokeratins results in collapse of the epithelial cell intermediate filament network. Nature. 352:1991;824-827.
16. Doorbar J., Medcalf E., Napthine S. Analysis of HPV1 E4 complexes and their association with keratinsin vivo. Virology. 218:1996;114-126.
17. Feilotter H. E., Hannon G. J., Ruddell C. J., Beach D. Construction of an improved host strain for two hybrid screening. Nucleic Acids Res. 22:1994;1502-1503.
18. Fields S., Song O. A novel genetic system to detect protein-protein interactions. Nature. 340:1989;245-246.
19. Gissmann L., Wolnik L., Ikenberg H., Koldovsky U., Schnurch H. G., zur Hausen H. Human papillomavirus types 6 and 11 DNA sequences in genital and laryngeal papillomas and in some cervical cancers. Proce. Natl. Acad. Sci. USA. 80:1983;560-563.
20. Howley, P. M. 1996, Papillomavirinae:, In, Fields Virology, B. N. FieldsD. M. KnipeP. M. HowleyR. M. ChanockJ. L. MelnickT. P. MonrathB. RoizmanS. E. Strasu, 2045, 2076, Lippincott-Raven, Philadelphia.
21. Jones S., Thornton J. M. Principles of protein-protein interactions. Proc. Natl. Acad. Sci. USA. 93:1996;13-20.
22. Keegan L., Gill G., Ptashne M. Separation of DNA binding from the transcription-activating function of a eukaryotic regulatory protein. Science. 231:1986;699-704.
23. Laemmli U. K. Cleavage of structural proteins during the assembly of the head of bacteriophage T4. Nature. 227:1970;680-685.
24. ∧. Virology. 159:1987;433-439.
25. Ormö M., Cubitt A. B., Kallio K., Gross L. A., Tsien R. Y., Remington S. J. Crystal structure of theAequorea victoria. Science. 273:1996;1392-1395.
26. Pfister H. Human papillomaviruses and genital cancer. Adv. Cancer Res. 48:1987;113-147.
27. Pray T. R., Laimins L. A. Differentiation-dependent expression of E1 similar to E4 proteins in cell lines maintaining episomes of human papillomavirus type 31b. Virology. 206:1995;679-685.
28. Roberts S., Ashmole I., Johnson G. D., Kreider J. W., Gallimore P. H. Cutaneous and mucosal human papillomavirus E4 proteins form intermediate filament-like structures in epithelial cells. Virology. 197:1993;176-187.
29. Rogel-Gaillard C., Breitburd F., Orth G. Human papillomavirus type 1 E4 proteins differing by their N-terminal ends have distinct cellular localizations when transiently expressed in vitro. J. Virol. 66:1992;816-823.
30. Rotenberg M. O., Chow L. T., Broker T. R. Characterization of rare human papillomavirus type 11 mRNAs coding for regulatory and structural proteins, using the polymerase chain reaction. Virology. 172:1989;489-497.
31. Saiki R. K., Gelfand D. H., Stoffel S., Scharf S. J., Higuchi R., Horn G. T., Mullis K. B., Erlich H. A. Primer-directed enzymatic amplification of DNA with a thermostable DNA polymerase. Science. 239:1988;487-491.
32. Sanger F., Nicklen S., Coulson A. R. DNA sequencing with chain-terminating inhibitors. Proc. Natl. Acad. Sci. USA. 74:1977;5463-5467.
33. Stoler M. H., Broker T. R. In situ hybridization detection of human papillomavirus DNAs and messenger RNAs in genital condylomas and a cervical carcinoma. Hum. Pathol. 17:1986;1250-1258.
34. Towbin H., Staehelin T., Gordon J. Electrophoretic transfer of proteins from polyacrylamide gels to nitrocellulose sheets: Procedure and some applications. Proc. Natl. Acad. Sci. USA. 76:1979;4350-4354.